BIOMAT Database Logo BIOMAT Database Logo

Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse. 1993

A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Department of Diabetes and Metabolism, St. Bartholomew's Hospital Medical College, London, UK.

The functional state of beta cells may influence the rate of their destruction in Type 1 (insulin-dependent) diabetes mellitus. We examined the effect of diazoxide, which inhibits insulin secretion, or tolbutamide, which stimulates insulin secretion, upon the incidence of diabetes in the non-obese-diabetic (NOD) mouse. Female mice were treated from 3-30 weeks of age with diet containing diazoxide 250 mg.kg-1 or tolbutamide 125 mg.kg-1. The cumulative incidence of diabetes at 35 weeks was similar in the diazoxide (16 of 24) and control (18 of 24) groups, but reduced in the tolbutamide group (10 of 23, p < 0.04 vs control group). In a second experiment, treatment was started from 9 weeks of age, by which time insulitis is already present. The cumulative incidence of diabetes at 35 weeks was 16 of 24 in controls, 15 of 24 on diazoxide and 11 of 24 on tolbutamide (p = NS vs control). A third experiment compared the effect of treatment from 3 weeks with control diet or diet containing tolbutamide 125 mg.kg-1 or 500 mg.kg-1. Diabetes was reduced by tolbutamide treatment, with a cumulative incidence of 25 of 31 in controls, 18 of 30 on tolbutamide 125 mg.kg-1 (p < 0.04) and 14 of 32 on 500 mg.kg-1 (p < 0.002), although the difference between the two treatment groups failed to reach statistical significance. A fourth experiment showed that treatment from 3-12 weeks with diazoxide 1000 mg.kg-1 increased the extent of insulitis compared with controls and animals treated with tolbutamide 500 mg.kg-1.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D010182 Pancreatic Diseases Pathological processes of the PANCREAS. Disease, Pancreatic,Diseases, Pancreatic,Pancreatic Disease
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D005260 Female Females
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014044 Tolbutamide A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Apo-Tolbutamide,Artosin,Diabetol,Diaval,Dolipol,Orabet,Orinase,Rastinon,Tolbutamid R.A.N.

Related Publications

A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice.
January 1991, Diabetologia,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NOD mice.
May 1992, The Journal of laboratory and clinical medicine,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Decreased incidence of diabetes mellitus by monosodium glutamate in the non-obese diabetic (NOD) mouse.
November 1985, Research communications in chemical pathology and pharmacology,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse.
June 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
In utero undernutrition reduces diabetes incidence in non-obese diabetic mice.
May 2007, Diabetologia,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Prospective prediction of spontaneous but not recurrent autoimmune diabetes in the non-obese diabetic mouse.
May 2007, Diabetologia,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice.
December 1994, International immunology,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
April 1993, The Journal of laboratory and clinical medicine,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
B lymphocytes not required for progression from insulitis to diabetes in non-obese diabetic mice.
December 2001, Immunology and cell biology,
A J Williams, and P E Beales, and J Krug, and E Procaccini, and A Signore, and S Xu, and E A Gale, and P Pozzilli
Detection of molecular paths associated with insulitis and type 1 diabetes in non-obese diabetic mouse.
October 2009, PloS one,
Copied contents to your clipboard!